1. Home
  2. CLST vs ICCC Comparison

CLST vs ICCC Comparison

Compare CLST & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLST
  • ICCC
  • Stock Information
  • Founded
  • CLST 1922
  • ICCC 1982
  • Country
  • CLST United States
  • ICCC United States
  • Employees
  • CLST N/A
  • ICCC N/A
  • Industry
  • CLST
  • ICCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLST
  • ICCC Health Care
  • Exchange
  • CLST Nasdaq
  • ICCC Nasdaq
  • Market Cap
  • CLST 52.5M
  • ICCC 60.1M
  • IPO Year
  • CLST N/A
  • ICCC 1987
  • Fundamental
  • Price
  • CLST $13.04
  • ICCC $5.95
  • Analyst Decision
  • CLST
  • ICCC
  • Analyst Count
  • CLST 0
  • ICCC 0
  • Target Price
  • CLST N/A
  • ICCC N/A
  • AVG Volume (30 Days)
  • CLST 2.5K
  • ICCC 8.2K
  • Earning Date
  • CLST 10-23-2025
  • ICCC 11-12-2025
  • Dividend Yield
  • CLST N/A
  • ICCC N/A
  • EPS Growth
  • CLST N/A
  • ICCC N/A
  • EPS
  • CLST 0.58
  • ICCC 0.20
  • Revenue
  • CLST $11,354,000.00
  • ICCC $28,274,756.00
  • Revenue This Year
  • CLST N/A
  • ICCC N/A
  • Revenue Next Year
  • CLST N/A
  • ICCC N/A
  • P/E Ratio
  • CLST $22.49
  • ICCC $29.50
  • Revenue Growth
  • CLST 164.54
  • ICCC 21.75
  • 52 Week Low
  • CLST $10.67
  • ICCC $3.34
  • 52 Week High
  • CLST $14.23
  • ICCC $7.60
  • Technical
  • Relative Strength Index (RSI)
  • CLST 62.70
  • ICCC 42.53
  • Support Level
  • CLST $12.66
  • ICCC $6.29
  • Resistance Level
  • CLST $13.22
  • ICCC $6.42
  • Average True Range (ATR)
  • CLST 0.15
  • ICCC 0.26
  • MACD
  • CLST 0.00
  • ICCC -0.03
  • Stochastic Oscillator
  • CLST 69.03
  • ICCC 22.79

About CLST Catalyst Bancorp Inc.

Catalyst Bancorp Inc is a bank holding company. Through its subsidiary, which is a federally chartered community-oriented savings bank, it is engaged in attracting deposits from the general public and using those funds to invest in loans and securities. The sources of funds are customer deposits, repayments of loans, maturities of investments, and funds borrowed from outside sources, which are used for the origination of loans. It derives income principally from interest earned on loans and investment securities and, to a lesser extent, from fees received in connection with the origination of loans, service charges on deposit accounts, and other services.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: